From the Moorfields Eye Hospital, London, United Kingdom.
J Cataract Refract Surg. 2020 Jan;46(1):138-142. doi: 10.1016/j.jcrs.2019.08.033.
Three patients using a postoperative combination of topical ketorolac (Acular) and neomycin/polymyxin B sulfate/dexamethasone (Maxitrol) were diagnosed with atypical keratopathy soon after routine cataract surgery. An immediate retrospective analysis of hospital patients who had used this topical drug combination in the previous year identified 10 other patients who also had significant corneal pathology after uneventful cataract surgery. Five of the 13 affected patients had corneal melting and 1 patient had corneal perforation and endophthalmitis. At the last recorded follow-up appointment, 8 of the 13 patients had a visual acuity of 6/36 or worse. Corneal melting is a rare complication of topical nonsteroidal anti-inflammatory drugs (NSAIDs). We propose that the combined use of topical NSAIDs and other agents, such as neomycin and benzalkonium, that further compromise the corneal epithelium, should be used with vigilance and increased awareness of potential keratopathy and permanent visual morbidity.
三位患者在常规白内障手术后不久,使用了术后组合制剂(典必殊),包括局部用酮咯酸(卡替洛尔)和新霉素/多粘菌素 B 硫酸盐/地塞米松,被诊断为非典型性角膜病。立即对过去一年中使用过这种局部药物组合的医院患者进行回顾性分析,发现另外 10 名患者在无并发症的白内障手术后也出现了明显的角膜病变。13 名受影响患者中有 5 名出现角膜融解,1 名出现角膜穿孔和眼内炎。在最后一次记录的随访预约中,13 名患者中有 8 名视力为 6/36 或更差。角膜融解是非甾体类抗炎药(NSAIDs)局部用药的罕见并发症。我们建议,应谨慎使用局部 NSAIDs 与其他药物(如新霉素和苯扎氯铵)联合应用,因为这些药物会进一步损害角膜上皮,同时增加对潜在角膜病和永久性视力损伤的认识。